wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36052253-07ECA05C-A3DF-4CFE-B975-92DDFDC8AE11
Q36052253-07ECA05C-A3DF-4CFE-B975-92DDFDC8AE11
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36052253-07ECA05C-A3DF-4CFE-B975-92DDFDC8AE11
Nivolumab and Olaparib.
P2860
Q36052253-07ECA05C-A3DF-4CFE-B975-92DDFDC8AE11
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36052253-07ECA05C-A3DF-4CFE-B975-92DDFDC8AE11
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7cad3d574e55573b2bf339453038a42aff670e74
P2860
Evaluation of the pharmacodynamics and pharmacokinetics of the PARP inhibitor olaparib: a phase I multicentre trial in patients scheduled for elective breast cancer surgery.